STOCKWATCH
·
Medical Specialities
Quarterly ResultMay 6, 2026, 04:07 PM

Clover Health Q1 GAAP Net Income $27M; Raises 2026 Outlook

AI Summary

Clover Health Investments, Corp. reported strong financial results for the first quarter of 2026, achieving positive GAAP Net Income of $27 million, a significant improvement from a loss in the prior year. The company saw substantial growth across key metrics, including a 62% increase in total revenues to $749 million and a 51% rise in Medicare Advantage membership. Management expects to meet or exceed its full-year 2026 outlook, including achieving its first full year of GAAP Net Income profitability.

Key Highlights

  • Clover Health reported Q1 2026 GAAP Net Income of $27 million, a $29 million improvement year-over-year.
  • Total revenues for Q1 2026 increased 62% year-over-year to $749 million.
  • Medicare Advantage membership grew 51% year-over-year to 155,773 in Q1 2026.
  • Consolidated Gross Profit for Q1 2026 was $160 million, up 47% year-over-year.
  • Adjusted EBITDA for Q1 2026 reached $40 million, a 56% increase year-over-year.
  • Full year 2026 GAAP Net Income is guided between $0 million and $20 million.
  • Full year 2026 Total revenues are projected between $2.81 billion and $2.92 billion.
  • Full year 2026 Average Medicare Advantage membership is guided between 154,000 and 158,000.
CLOV
Medical Specialities
CLOVER HEALTH INVESTMENTS, CORP. /DE

Price Impact